Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P04150: Variant p.Asp641Val

Glucocorticoid receptor
Gene: NR3C1
Feedback?
Variant information Variant position: help 641 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Aspartate (D) to Valine (V) at position 641 (D641V, p.Asp641Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to medium size and hydrophobic (V) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In GCCR. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 641 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 777 The length of the canonical sequence.
Location on the sequence: help LCFAPDLIINEQRMTLPCMY D QCKHMLYVSSELHRLQVSYE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LCFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYE

Mouse                         LCFAPDLIINEQRMTLPCMYDQCKHMLFISTELQRLQVSYE

Rat                           LCFAPDLIINEQRMSLPCMYDQCKHMLFVSSELQRLQVSYE

Pig                           LCFAPDLVINEQRMALPCMYDQCRHMLYVSSELQRLQVSYE

Rabbit                        LCFAPDLVINEQRMTLPYMYDQCKHMLFVSSELKRLQVSYE

Xenopus laevis                LYFAPDLVITEDRMHLPFMQERCQEMLKIAGEMSSLQISYD
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 777 Glucocorticoid receptor
Domain 524 – 758 NR LBD
Region 485 – 777 Interaction with CLOCK
Region 532 – 697 Interaction with CRY1
Alternative sequence 491 – 674 Missing. In isoform GR-A alpha and isoform GR-A beta.
Mutagenesis 625 – 625 P -> A. Decreases transactivation by dexamethasone by 95%.
Mutagenesis 628 – 628 I -> A. Decreases dimerization and transactivation by dexamethasone; when associated with S-602.
Helix 639 – 655



Literature citations
Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance.
Hurley D.M.; Accili D.; Stratakis C.A.; Karl M.; Vamvakopoulos N.; Rorer E.; Constantine K.; Taylor S.I.; Chrousos G.P.;
J. Clin. Invest. 87:680-686(1991)
Cited for: CHARACTERIZATION OF VARIANT GCCR VAL-641;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.